Welcome to CDC stacks | Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012 - 35535 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
Filetype[PDF-1.05 MB]


Details:
No Related Documents.
You May Also Like:
  1. Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger
    Personal Author:
    Maïnassara, Halima Boubacar; Paireau, Juliette; Idi, Issa; Pelat, Jean-Paul Moulia; Oukem-Boyer, Odile Ouwe Missi; Fontanet, Arnaud; Mueller, Judith E.;
    Published:
    Aug 2015
    Source:
    Emerg Infect Dis. 21(8):1322-1329.
    Description:
    To inform epidemic response strategies for the African meningitis belt after a meningococcal serogroup A conjugate vaccine was introduced in 2010, we compared the effectiveness and efficiency of meningitis surveillance and vaccine response strategies...
    File Type:
    Filetype[PDF - 1.90 MB]
  2. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014
    Personal Author:
    Djingarey, Mamoudou H.; Diomandé, Fabien V. K.; Barry, Rodrigue; Kandolo, Denis; Shirehwa, Florence; Lingani, Clement; Novak, Ryan T.; Tevi-Benissan, Carol; Perea, William; Preziosi, Marie-Pierre; LaForce, F. Marc;
    Published:
    Nov 15 2015
    Source:
    Clin Infect Dis. 2015; 61(Suppl 5):S434-S441.
    Description:
    A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African "meningitis belt" and was prequalified by the World Health Organization (WHO) in June 2010. The vaccine was first used widely in Burkina Faso, Mali, and Nig...
    File Type:
    Filetype[PDF - 347.17 KB]
  3. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013
    Personal Author:
    Kambiré, Dinanibè; Soeters, Heidi M.; Ouédraogo-Traoré, Rasmata; Medah, Isaïe; Sangare, Lassana; Yaméogo, Issaka; Sawadogo, Guetawendé; Ouédraogo, Abdoul-Salam; Hema-Ouangraoua, Soumeya; McGee, Lesley; Srinivasan, Velusamy; Aké, Flavien; Congo-Ouédraogo, Malika; Sanou, Soufian; Ba, Absatou Ky; Novak, Ryan T.; Van Beneden, Chris;
    Corporate Author:
    MenAfriNet Consortium
    Published:
    Nov 10 2016
    Source:
    PLoS One. 11(11).
    Description:
    Background : Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe ...
    File Type:
    Filetype[PDF - 1.78 MB]
  4. Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015
    Personal Author:
    Coldiron, Matthew E.; Salou, Halidou; Sidikou, Fati; Goumbi, Kadadé; Djibo, Ali; Lechevalier, Pauline; Compaoré, Idrissa; Grais, Rebecca F.;
    Published:
    Oct 2016
    Source:
    Emerg Infect Dis. 22(10):1827-1829.
    Description:
    We describe clinical symptoms, case-fatality rates, and prevalence of sequelae during an outbreak of Neisseria meningitidis serogroup C infection in a rural district of Niger. During home visits, we established that household contacts of reported cas...
    File Type:
    Filetype[PDF - 1.39 MB]
  5. Neisseria meningitidis Serogroup W, Burkina Faso, 2012
    Personal Author:
    MacNeil, Jessica R.; Medah, Isaïe; Koussoubé, Daouda; Novak, Ryan T.; Cohn, Amanda C.; Diomandé, Fabien V.K.; Yelbeogo, Denis; Kambou, Jean Ludovic; Tarbangdo, Tiga F.; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Hatcher, Cynthia; Vuong, Jeni; Mayer, Leonard W.; Djingarey, Mamoudou H.; Clark, Thomas A.; Messonnier, Nancy E.;
    Published:
    Mar 2014
    Source:
    Emerg Infect Dis. 20(3):394-399.
    Description:
    In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a n...
    File Type:
    Filetype[PDF - 576.47 KB]